Revelation Biosciences, Inc. (REVB)
3.50
-0.29
(-7.65%)
USD |
NASDAQ |
Oct 26, 16:00
3.50
0.00 (0.00%)
After-Hours: 20:00
Revelation Biosciences Price to Book Value : 0.1941 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.2102 |
| October 22, 2026 | 0.2041 |
| October 21, 2026 | 0.1997 |
| October 20, 2026 | 0.208 |
| October 19, 2026 | 0.1822 |
| October 16, 2026 | 0.1882 |
| October 15, 2026 | 0.2959 |
| October 14, 2026 | 0.2794 |
| October 13, 2026 | 0.2835 |
| October 12, 2026 | 0.3007 |
| October 09, 2026 | 0.295 |
| October 08, 2026 | 0.3004 |
| October 07, 2026 | 0.3215 |
| October 06, 2026 | 0.292 |
| October 05, 2026 | 0.3017 |
| October 02, 2026 | 0.2964 |
| October 01, 2026 | 0.311 |
| September 30, 2026 | 0.3172 |
| September 29, 2026 | 0.316 |
| September 28, 2026 | 0.3336 |
| September 25, 2026 | 0.3378 |
| September 24, 2026 | 0.3378 |
| September 23, 2026 | 0.3627 |
| September 22, 2026 | 0.3804 |
| September 21, 2026 | 0.379 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.3612 |
| September 17, 2026 | 0.3688 |
| September 16, 2026 | 0.3572 |
| September 15, 2026 | 0.3534 |
| September 14, 2026 | 0.3708 |
| September 11, 2026 | 0.3853 |
| September 10, 2026 | 0.388 |
| September 09, 2026 | 0.3921 |
| September 08, 2026 | 0.3921 |
| September 04, 2026 | 0.3921 |
| September 03, 2026 | 0.3921 |
| September 02, 2026 | 0.3882 |
| September 01, 2026 | 0.383 |
| August 31, 2026 | 0.3882 |
| August 28, 2026 | 0.4076 |
| August 27, 2026 | 0.3999 |
| August 26, 2026 | 0.3707 |
| August 25, 2026 | 0.3882 |
| August 24, 2026 | 0.427 |
| August 21, 2026 | 0.4231 |
| August 20, 2026 | 0.4154 |
| August 19, 2026 | 0.4309 |
| August 18, 2026 | 0.4309 |
| August 17, 2026 | 0.4464 |
| August 14, 2026 | 0.4072 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 0.2683 |
| ACADIA Pharmaceuticals, Inc. | 2.600 |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 22.48 |
| Amgen, Inc. | 20.57 |
Price to Book Value Related Metrics
| Price | 3.50 |
| Earnings Yield | -2.46K% |
| Market Cap | 1.954M |